Injury-Dependent Retention of Intraportally Administered Mesenchymal Stromal Cells Following Partial Hepatectomy of Steatotic Liver Does Not Lead to Improved Liver Recovery

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Boeykens, Nele ^a   Ponsaerts, Peter ^b   Van der Linden, Annemie ^b   Berneman, Zwi ^b   Ysebaert, Dirk ^a   De Greef, Kathleen ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CHOLINESTERASE; LENTIVIRUS VECTOR; METHIONINE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BODY WEIGHT; BONE MARROW DERIVED MESENCHYMAL STROMA CELL; CONTROLLED STUDY; DIET; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; FLOW CYTOMETRY; HISTOLOGY; LIVER FUNCTION; LIVER REGENERATION; LIVER WEIGHT; MESENCHYMAL STROMA CELL; NONHUMAN; PARTIAL HEPATECTOMY; RAT; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CHOLINE DEFICIENCY; CHOLINESTERASES; DNA PRIMERS; FATTY LIVER; FEMALE; FLOW CYTOMETRY; HEPATECTOMY; IMMUNOPHENOTYPING; LIVER REGENERATION; LUMINESCENT MEASUREMENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; METHIONINE; ORGAN SIZE; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 84880417799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069092     Document Type: Article

References (45)

1. Michalopoulos GK, (2007) Liver regeneration. J Cell Physiol 213: 286-300. doi:10.1002/jcp.21172. PubMed: 17559071.
2. Veteläinen R, van Vliet A, Gouma DJ, van Gulik TM, (2007) Steatosis as a risk factor in liver surgery. Ann Surg 245: 20-30. doi:10.1097/01.sla.0000225113.88433.cf. PubMed: 17197961.
3. Veteläinen R, van Vliet AK, van Gulik TM, (2007) Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg 245: 44-50. doi:10.1097/01.sla.0000225253.84501.0e. PubMed: 17197964.
4. Selzner M, Clavien PA, (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21: 105-113. doi:10.1055/s-2001-12933. PubMed: 11296690.
5. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA, (2007) Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 245: 923-930. doi:10.1097/01.sla.0000251747.80025.b7. PubMed: 17522518.
6. Kele PG, van der Jagt EJ, Gouw AS, Lisman T, Porte RJ, et al. (2012) The impact of hepatic steatosis on liver regeneration after partial hepatectomy. Liver Int, 33: 469-75. PubMed: 23311417.
7. Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, et al. (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94: 1395-1402. doi:10.1002/bjs.5820. PubMed: 17607707.
8. Fisher RA, Strom SC, (2006) Human hepatocyte transplantation: worldwide results. Transplantation 82: 441-449. doi:10.1097/00007890-200607152-01110. PubMed: 16926585.
9. Fox IJ, Chowdhury JR, (2004) Hepatocyte transplantation. Am J Transplant 4 (Suppl 6):: 7-13. doi:10.1111/j.1600-6135.2004.0biograp.x. PubMed: 14871269.
10. Grompe M, (2001) Liver repopulation for the treatment of metabolic diseases. J Inherit Metab Dis 24: 231-244. doi:10.1023/A:1010375203539. PubMed: 11405342.
11. Walldorf J, Aurich H, Cai H, Runge D, Christ B, et al. (2004) Expanding hepatocytes in vitro before cell transplantation: donor age-dependent proliferative capacity of cultured human hepatocytes. Scand J Gastroenterol 39: 584-593. doi:10.1080/00365520410005586. PubMed: 15223685.
12. Cho KA, Ju SY, Cho SJ, Jung YJ, Woo SY, et al. (2009) Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int 33: 772-777. doi:10.1016/j.cellbi.2009.04.023. PubMed: 19427913.
13. Aziz, Abdel, Atta HM, Mahfouz S, Fouad HH, Roshdy NKet al. (2007) Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 40: 893-899. doi:10.1016/j.clinbiochem.2007.04.017. PubMed: 17543295.
14. Pelz S, Stock P, Brückner S, Christ B, (2012) A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. Exp Cell Res 318: 276-287. doi:10.1016/j.yexcr.2011.11.005. PubMed: 22108588.
15. Seki T, Yokoyama Y, Nagasaki H, Kokuryo T, Nagino M, (2012) Adipose tissue-derived mesenchymal stem cell transplantation promotes hepatic regeneration after hepatic ischemia-reperfusion and subsequent hepatectomy in rats. J Surg Res, 178: 63-70. PubMed: 22482751.
16. Kaibori M, Adachi Y, Shimo T, Ishizaki M, Matsui K, et al. (2012) Stimulation of liver regeneration after hepatectomy in mice by injection of bone marrow mesenchymal stem cells via the portal vein. Transplant Proc 44: 1107-1109. doi:10.1016/j.transproceed.2012.01.088. PubMed: 22564637.
17. Zhang Z, Lin H, Shi M, Xu R, Fu J, et al. (2012) Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 27 (Suppl 2):: 112-120. doi:10.1111/j.1440-1746.2011.07024.x. PubMed: 22320928.
18. Mitchell C, Willenbring H, (2008) A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 3: 1167-1170. doi:10.1038/nprot.2008.80. PubMed: 18600221.
19. Bergwerf I, De Vocht N, Tambuyzer B, Verschueren J, Reekmans K, et al. (2009) Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol 9: 1. doi:10.1186/1472-6750-9-1. PubMed: 19128466.
20. Reumers V, Deroose CM, Krylyshkina O, Nuyts J, Geraerts M, et al. (2008) Noninvasive and quantitative monitoring of adult neuronal stem cell migration in mouse brain using bioluminescence imaging. Stem Cells 26: 2382-2390. doi:10.1634/stemcells.2007-1062. PubMed: 18599812.
21. Bergwerf I, Tambuyzer B, De Vocht N, Reekmans K, Praet J, et al. (2011) Recognition of cellular implants by the brain's innate immune system. Immunol Cell Biol 89: 511-516. doi:10.1038/icb.2010.141. PubMed: 21102538.
22. De Vocht N, Bergwerf I, Vanhoutte G, Daans J, De Visscher G, et al. (2011) Labeling of Luciferase/eGFP-expressing bone marrow-derived stromal cells with fluorescent micron-sized iron oxide particles improves quantitative and qualitative multimodal imaging of cellular grafts in vivo. Mol Imaging Biol 13: 1133-1145. doi:10.1007/s11307-011-0469-3. PubMed: 21246293.
23. De Vocht N, Reekmans K, Bergwerf I, Praet J, Hoornaert C, et al. (2012) Multimodal imaging of stem cell implantation in the central nervous system of mice. J Vis Exp: pp. e3906. PubMed: 22733218.
24. Reekmans K, Praet J, Daans J, Reumers V, Pauwels P, et al. (2012) Current challenges for the advancement of neural stem cell biology and transplantation research. Stem Cell Rev 8: 262-278. doi:10.1007/s12015-011-9266-2. PubMed: 21537994.
25. Reekmans KP, Praet J, De Vocht N, Tambuyzer BR, Bergwerf I, et al. (2011) Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? Cell Transplant 20: 851-869. doi:10.3727/096368910X543411. PubMed: 21092405.
26. Ysebaert DK, De Greef KE, Vercauteren SR, Verhulst A, Kockx M, et al. (2003) Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 64: 864-873. doi:10.1046/j.1523-1755.2003.00150.x. PubMed: 12911536.
27. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321. doi:10.1002/hep.20701. PubMed: 15915461.
28. Veteläinen R, Bennink RJ, van Vliet AK, van Gulik TM, (2007) Mild steatosis impairs functional recovery after liver resection in an experimental model. Br J Surg 94: 1002-1008. doi:10.1002/bjs.5672. PubMed: 17497653.
29. Michalopoulos GK, DeFrances MC, (1997) Liver regeneration. Science 276: 60-66. doi:10.1126/science.276.5309.60. PubMed: 9082986.
30. Sydor S, Gu Y, Schlattjan M, Bechmann LP, Rauen U, et al. (2013) Steatosis does not impair liver regeneration after partial hepatectomy. Lab Invest 93: 20-30. doi:10.1038/labinvest.2012.142. PubMed: 23069937.
31. Yamaguchi K, Itoh Y, Yokomizo C, Nishimura T, Niimi T, et al. (2010) Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice. Lab Invest 90: 1169-1178. doi:10.1038/labinvest.2010.75. PubMed: 20368703.
32. Garbow JR, Kataoka M, Flye MW, (2004) MRI measurement of liver regeneration in mice following partial hepatectomy. Magn Reson Med 52: 177-180. doi:10.1002/mrm.20107. PubMed: 15236383.
33. Everaert BR, Bergwerf I, De Vocht N, Ponsaerts P, Van Der Linden A, et al. (2012) Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing. BMC Biotechnol 12: 93. doi:10.1186/1472-6750-12-93. PubMed: 23206380.
34. Benten D, Follenzi A, Bhargava KK, Kumaran V, Palestro CJ, et al. (2005) Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice. Hepatology 42: 140-148. doi:10.1016/S0168-8278(05)81791-X. PubMed: 15918158.
35. Cheng K, Benten D, Bhargava K, Inada M, Joseph B, et al. (2009) Hepatic targeting and biodistribution of human fetal liver stem/progenitor cells and adult hepatocytes in mice. Hepatology 50: 1194-1203. doi:10.1002/hep.23120. PubMed: 19637284.
36. Michalopoulos GK, (2010) Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 176: 2-13. doi:10.2353/ajpath.2010.090675. PubMed: 20019184.
37. Boxall SA, Jones E, (2012) Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int, 2012(2012): 975871. PubMed: 22666272.
38. Reekmans K, Praet J, De Vocht N, Daans J, Van der Linden A, et al. (2012) Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt? Regen: Med 7: 245-259.
39. Stock P, Brückner S, Ebensing S, Hempel M, Dollinger MM, et al. (2010) The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc 5: 617-627. doi:10.1038/nprot.2010.7. PubMed: 20224562.
40. Koteish A, Diehl AM, (2002) Animal models of steatohepatitis. Best Practice Res Clin Gastroenterol 16: 679-690. doi:10.1053/bega.2002.0332. PubMed: 12406439.
41. Stöppeler S, Palmes D, Fehr M, Hölzen JP, Zibert A, et al. (2013) Gender and strain-specific differences in the development of steatosis in rats. Lab Anim 47: 43-52. doi:10.1177/0023677212473717. PubMed: 23467489.
42. Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, et al. (2003) Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 18: 1272-1282. doi:10.1046/j.1440-1746.2003.03198.x. PubMed: 14535984.
43. Romestaing C, Piquet MA, Bedu E, Rouleau V, Dautresme M, et al. (2007) Long term highly saturated fat diet does not induce NASH in Wistar rats. Nutr Metab (Lond) 4: 4. doi:10.1186/1743-7075-4-4.
44. Takahashi Y, Soejima Y, Fukusato T, (2012) Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 18: 2300-2308. doi:10.3748/wjg.v18.i19.2300. PubMed: 22654421.
45. Romestaing C, Piquet MA, Bedu E, Rouleau V, Dautresme M, et al. (2007) Long term highly saturated fat diet does not induce NASH in Wistar rats. Nutr Metab 4.